Glutathione S – transferases class Pi and Mi and their significance in oncology

COMMENTARY ON THE LAW

Glutathione S – transferases class Pi and Mi and their significance in oncology

Zofia Marchewka 1 , Agnieszka Piwowar 2 , Sylwia Ruzik 2 , Anna Długosz 2

1. Pracownia Markerów Nefrotoksyczności Środowiskowej Uniwersytetu Medycznego im. Piastów Śląskich we Wrocławiu
2. Katedra i Zakład Toksykologii Uniwersytetu Medycznego im. im. Piastów Śląskich we Wrocławiu

Published: 2017-06-19
DOI: 10.5604/01.3001.0010.3835
GICID: 01.3001.0010.3835
Available language versions: en pl
Issue: Postepy Hig Med Dosw 2017; 71 : 541-550

 

Abstract

In this article the current data, which shows that glutathione S-transferases (GST) class Pi and Mi are interesting and promising biomarkers in acute and chronic inflammatory processes as well as in the oncology, were presented based on the review of the latest experimental and clinical studies. The article shows their characteristics, functions and participation (direct – GST Pi, indirect – GST Mi) in the regulation of signaling pathways of JNK kinases, which are involved in cell differentiation. Overexpression of glutathione S-transferases class Pi and Mi in many cancer cells plays a key role in cancer treatment, making them resistant to chemotherapy. GST isoenzymes are involved in the metabolism of various types of xenobiotics and endogenous substrates, so their altered expression in cancer tissues as well as in serum and urine could be an important potential marker of the cancer and an indicator of oxidative stress. The study shows the role of glutathione S-transferases in redox homeostasis of tumor cells and in the mechanism of resistance to anticancer drugs.

References

  • 1. Abid A., Ajaz S., Khan A.R., Zehra F., Hasan A.S., Sultan G., Mohsin R., Hashmi A., Niamatullah N., Rizvi S.A., Mehdi S.Q., Khaliq S.: Analysis of the glutathione S-transferase genes polymorphisms in the risk and prognosis of renal cell carcinomas. Case-control and meta-analysis. Urol. Oncol., 2016; 34: 419.e1-419.e12
    Google Scholar
  • 2. Aktas D., Ozen H., Atsu N., Tekin A., Sozen S., Tuncbilek E.: Glutathione S-transferase M1 gene polymorphism in bladder cancer patients: a marker for invasive bladder cancer? Cancer Genet. Cytogenet., 2001; 125: 1-4
    Google Scholar
  • 3. Bhattacharjee P., Paul S., Banerjee M., Patra D., Banerjee P., Ghoshal N., Bandyopadhyay A., Giri A.K.: Functional compensation of glutathione S-transferase M1 (GSTM1) null by another GST superfamily member, GSTM2. Sci. Rep., 2013; 3: 2704
    Google Scholar
  • 4. Board P.G., Menon D.: Glutathione transferases, regulators of cellular metabolism and physiology. Biochim. Biophys. Acta, 2013; 1830: 3267-3288
    Google Scholar
  • 5. Budzik M.P., Badowska-Kozakiewicz A.M.: Oporność wielolekowa związana z glutationem. Prz. Menopauz., 2013; 5: 399-403
    Google Scholar
  • 6. Conklin D.J., Haberzettl P., Lesgards J.F., Prough R.A., Srivastava S., Bhatnagar A.: Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity. J. Pharmacol. Exp. Ther., 2009; 331: 456-469
    Google Scholar
  • 7. Dalle-Donne I., Rossi R., Giustarini D., Colombo R., Milzani A.: S-glutathionylation in protein redox regulation. Free Radic. Biol. Med., 2007; 43: 883-898
    Google Scholar
  • 8. Depeille P., Cuq P, Mary S, Passagne I, Evrard A, Cupissol D, Vian L.: Glutathione S-transferase M1 and multidrug resistance protein 1 act in synergy to protect melanoma cells from vincristine effects. Mol. Pharmacol., 2004; 65: 897-905
    Google Scholar
  • 9. Djukic T.I., Savic-Radojevic A.R., Pekmezovic T.D., Matic M.G., Pljesa-Ercegovac M.S., Coric V.M., Radic T.M., Suvakov S.R., Krivic B.N., Dragicevic D.P. Simic T.P.: Glutathione S-transferase T1, O1 and O2 polymorphisms are associated with survival in muscle invasive bladder cancer patients. PLoS One, 2013; 8: e74724
    Google Scholar
  • 10. Drozd E., Krzysztoń-Russjan J., Marczewska J., Drozd J., Bubko I., Bielak M., Lubelska K., Wiktorska K., Chilmonczyk Z., Anuszewska E., Gruber-Bzura B.: Up-regulation of glutathione-related genes, enzy me activities and transport proteins in human cervical cancer cells treated with doxorubicin. Biomed. Pharmacother., 2016; 83: 397-406
    Google Scholar
  • 11. Gartia-Closas M., Malats N., Silverman D., Dosemeci M., Kogevinas M., Hein D.W., Tardón A., Serra C., Carrato A., Garda-Closas R., Lloreta J., Castano-Vinyals G., Yeager M., Welch R., Chanock S. i wsp.: NAT2 slow acetylation and GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet, 2005; 366: 649-659
    Google Scholar
  • 12. Giannakopoulos X., Charalabopoulos K., Baltogiannis D., Chatzikiriakidou A., Alamanos Y., Georgiou I., Evangelou A., Agnantis N., Sofikitis N.: The role of N- acetyltransferase-2 and glutathione S-transferase on the risk and aggressiveness of bladder cancer. Anticancer Res., 2002; 22: 3801-3804
    Google Scholar
  • 13. Goto S., Ihara Y., Urata Y., Izumi S., Abe K., Koji T., Kondo T.: Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase π. FASEB J., 2001; 15: 2702-2714
    Google Scholar
  • 14. Guven M., Unal S., Erhan D., Ozdemir N., Baris S., Celkan T., Bostanci M., Batar B.: Role of glutathione S-transferase M1, T1 and P1 gene polymorphisms in childhood acute lymphoblastic leukemia susceptibility in a Turkish population. Meta Gene, 2015; 5: 115-119
    Google Scholar
  • 15. Hung R.J., Boffetta P., Brennan P., Malaveille C., Hautefeuille A., Donato F., Gelatti U., Spaliviero M., Placidi D., Carta A., Scotto Di Carlo A., Porru S.: GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int. J. Cancer, 2004; 110: 598-604
    Google Scholar
  • 16. Jardim B.V., Moschetta M.G., Gelaleti G.B., Leonel C., Regiani V.R., de Santi Neto D., Bordin-Junior N.A., Perea S.A., Zuccari D.A.: Glutathione transferase pi (GSTpi) expression in breast cancer: an immunohistochemical and molecular study. Acta Histochem., 2012; 114: 510-517
    Google Scholar
  • 17. Josephy P.D.: Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology. Hum. Genomics Proteomics, 2010; 2010: 876940
    Google Scholar
  • 18. Kang H., Song P.H., Ha Y.S., Kim W.T., Kim Y.J., Yun S.J., Lee S.C., Choi Y.H., Moon S.K., Kim W.J.: Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients. Eur. J. Cancer, 2013; 49: 3010-3019
    Google Scholar
  • 19. Karagas M.R., Park S., Warren A., Hamilton J., Nelson H.H., Mott L.A., Kelsey K.T.: Gender, smoking, glutathione S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett., 2005; 219: 63-69
    Google Scholar
  • 20. Karwicka E.: Rola glutationu w oporności wielolekowej nowotworów. Post. Biol. Kom., 2010; 37: 323-341
    Google Scholar
  • 21. Khedhiri S., Stambouli N., Ouerhani S., Roussi K., Marrakchi R., Gaaied A.B., Slama M.B.: The impact of smoking and polymorphic enzymes of xenobiotic metabolism on the stage of bladder tumors: a generalized ordered logistic regression analysis. J. Cancer Res. Clin. Oncol., 2010; 136: 1111-1116
    Google Scholar
  • 22. Li J., Long J., Hu Y., Tan A., Guo X., Zhang S.: Glutathione S-transferase M1, T1 and P1 polymorphisms and thyroid cancer risk: A meta-analysis. Cancer Epidemiol., 2012; 36: e333-e340
    Google Scholar
  • 23. Lo H.W., Ali-Osman F.: Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance. Curr. Opin. Pharmacol., 2007; 7: 367-374
    Google Scholar
  • 24. Matic M, Simic T., Dragicevic D., Mimic-Oka J., Pljesa-Ercegovac M., Savic- Radojevic A.: Isoenzyme profile of glutathione transferases in transitional cell carcinoma of upper urinary tract. Transl. Res., 2010; 155: 256-262
    Google Scholar
  • 25. Matic M.G., Coric V.M., Savic-Radojevic A. R., Bulat P.V., Pljesa-Ercegovac M.S., Dragicevic D.P., Djukic T.I., Simic T.P., Pekmezovic T.D.: Does occupational exposure to solvents and pesticides in association with glutathione S-transferase A1, M1, P1 and T1 polymorphisms increase the risk of bladder cancer? The Belgrade Case-Control Study. PLoS One, 2014; 9: e99448
    Google Scholar
  • 26. McIlwain C.C., Townsend D.M., Tew K.D.: Glutathione S transferase polymorphisms: cancer incidence and therapy. Oncogene, 2006; 25: 1639-1648
    Google Scholar
  • 27. Oakley A.: Glutathione transferases: a structural perspective. Drug Metab. Rev., 2011; 43: 138-151
    Google Scholar
  • 28. Oguri T., Fujiwara Y., Katoh O., Daga H., Ishikawa N., Fujitaka K., Yamasaki M., Yokozaki M., Isobe T., Ishioka S., Yamakido M.: Glutathione S-transferase-π gene expression and platinum drug exposure in human lung cancer. Cancer Lett., 2000; 156: 93-99
    Google Scholar
  • 29. Pandith A.A., Lateef A., Shahnawaz S., Hussain A., Malla T.M., Azad N., Shehjar F., Salim M., Shah Z.A.: GSTP1 gene Ile105Val polymorphism causes an elevated risk for bladder carcinogenesis in smokers. Asian Pac. J. Cancer Prev., 2013; 14: 6375-6378
    Google Scholar
  • 30. Parker L.J., Ciccone S., Italiano L.C., Primavera A., Oakley A.J., Morton C.J., Hancock N.C., Bello M.L., Parker M.W.: The anti-cancer drug chlorambucil as a substrate for the human polymorphic enzyme glutathione transferase P1-1: kinetic properties and crystallographic characterisation of allelic variants. J. Mol. Biol., 2008; 380: 131-144
    Google Scholar
  • 31. Peklak-Scott C., Smitherman P.K., Townsend A.J., Morrow C.S.: The role of glutathione S-transferase P1-1 (GSTP1-1) in the cellular detoxification of cisplatin. Mol. Cancer Ther., 2008; 7: 3247-3255
    Google Scholar
  • 32. Pljesa-Ercegovac M., Savic-Radojevic A., Dragicevic D., Mimic- -Oka J., Matic M., Sasic T., Pekmezovic T., Vuksanovic A., Simic T.: Enhanced GSTP1 expression in transitional cell carcinoma of urinary bladder is associated with altered apoptotic pathways. Urol. Oncol., 2011; 29: 70-77
    Google Scholar
  • 33. Ramos D. L., Gaspar J.F., Pingarilho M., Gil O.M., Fernandes A.S., Rueff J., Oliveira N.G.: Genotoxic effects of doxorubicin in cultured human lymphocytes with different glutathione S-transferase genotypes. Mutat. Res., 2011; 724: 28-34
    Google Scholar
  • 34. Raza H.: Dual localization of glutathione S-transferase in the cytosol and mitochondria: implications in oxidative stress, toxicity and disease. FEBS J., 2011; 278: 4243-4251
    Google Scholar
  • 35. Rouissi K., Ouerhani S., Marrakchi R., Ben Slama M.R., Sfaxi M., Ayed M., Chebil M., El Gaaied A.B.: Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population. Cancer Genet. Cytogenet., 2009; 190: 101-107
    Google Scholar
  • 36. Safarinejad M.R., Safarinejad S., Shafiei N., Safarinejad S.: Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility. Urol. Oncol., 2013; 31: 1193-1203
    Google Scholar
  • 37. Sau A., Pellizzari-Tregno F., Valentino F., Federici G., Caccuri A.M.: Glutathione transferases and development of new principles to overcome drug resistance. Arch. Biochem. Biophys., 2010; 500: 116-122
    Google Scholar
  • 38. Savic-Radojevic A., Mimic-Oka J., Pljesa-Ercegovac M., Opacic M., Dragicevic D., Kravic T., Djokic M., Mimic S., Simic T.: Glutathione S-transferase P1 expression correlates with increased antioxidant capacity in transitional cell carcinoma of the urinary bladder. Eur. Urol., 2007; 52: 470-477
    Google Scholar
  • 39. Schnekenburger M., Karius T., Diederich M.: Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosis. Front. Pharmacol., 2014; 5: 170
    Google Scholar
  • 40. Scibior-Bentkowska D., Czeczot H.: Komórki nowotworowe a stres oksydacyjny. Postępy Hig. Med. Dośw., 2009; 63: 58-72
    Google Scholar
  • 41. Sharma T., Jain S., Verma A., Sharma N., Gupta S., Arora V.K., Dev Banerjee B.: Gene environment interaction in urinary bladder cancer with special reference to organochlorine pesticide: a case control study. Cancer Biomark., 2013; 13: 243-251
    Google Scholar
  • 42. Sherratt P.J., Hayes J.D.: Glutathione S-transferases. W: Enzyme systems that metabolise drugs and other xenobiotics, red.: C. Joannides, John Wiley& Sons Ltd, Chichester UK, 2001, 319-352
    Google Scholar
  • 43. Simic T., Mimic-Oka J., Savic-Radojevic A., Opacic M., Pljesa M., Dragicevic D., Djokic M., Radosavljevic R.: Glutathione S-transferase T1-1 activity upregulated in transitional cell carcinoma of urinary bladder. Urology, 2005; 65: 1035-1040
    Google Scholar
  • 44. Simic T., Savic-Radojevic A., Pljesa-Ercegovac M., Matic M., Mimic-Oka J.: Glutathione S-transferases in kidney and urinary bladder tumors. Nat. Rev. Urol., 2009; 6: 281-289
    Google Scholar
  • 45. Simic T., Savic-Radojevic A., Pljesa-Ercegovac M., Matic M., Sasic T., Dragicevic D., Mimic-Oka J.: The role of glutathione S-transferases in urinary tract tumors. JMB, 2008; 27: 360-366
    Google Scholar
  • 46. Singh S.: Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death. Cancer Chemother. Pharmacol., 2015; 75: 1-15
    Google Scholar
  • 47. Sohail A., Kanwal N., Ali M., Sadia S., Masood A.I., Ali F., Iqbal F., Crickmore N., Shaikh R.S., Sayyed A.H.: Effects of glutathione-S- -transferase polymorphisms on the risk of breast cancer: a population-based case-control study in Pakistan. Environ. Toxicol. Pharmacol., 2013; 35: 143-153
    Google Scholar
  • 48. Soudy R., Chen C, Kaur K.: Novel peptide-doxorubucin conjugates for targeting breast cancer cells including the multidrug resistant cells. J. Med. Chem., 2013; 56: 7564-7573
    Google Scholar
  • 49. Srivastava D.S., Mishra D.K., Mandhani A., Mittal B., Kumar A., Mittal R.D.: Association of genetic polymorphism of glutathione S- -transferase M1, T1, P1 and susceptibility to bladder cancer. Eur. Urol., 2005; 48: 339-344
    Google Scholar
  • 50. Tew K.D.: Redox in redux: emergent roles for glutathione S- -transferase P (GSTP) in regulation of cell signaling and S-glutathionylation. Biochem. Pharmacol., 2007; 73: 1257-1269
    Google Scholar
  • 51. Tew K.D., Manevich Y., Grek C., Xiong Y., Uys J., Townsend D.M.: The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer. Free Radic. Biol. Med., 2011; 51: 299-313
    Google Scholar
  • 52. Townsend D.M., Tew K.D., He L., King J.B., Hanigan M.H.: Role of glutathione S-transferase Pi in cisplatin-induced nephrotoxicity. Biomed. Pharmacother., 2009; 63: 79-85
    Google Scholar
  • 53. Włodek L., Iciek M.: S-tiolacja białek jako mechanizm antyoksydacyjny i regulacyjny. Postępy Biochem., 2003; 49: 77-84
    Google Scholar
  • 54. Wojas-Krawczyk K., Krawczyk P., Chocholska S., Góra A., Mackiewicz B., Ciesielka M., Kozioł P., Milanowski J.: CYP1A1, GSTT1, and GSTM1 polymorphisms and lung cancer in Eastern Poland. Adv. Clin. Exp. Med., 2009; 18: 461-471
    Google Scholar
  • 55. Yuan J.M., Chan K.K., Coetzee G.A., Castelao J.E., Watson M.A., Bell D.A., Wang R., Yu M.C.: Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer. Carcinogenesis, 2008; 29: 1386-1393
    Google Scholar
  • 56. Zhang J., Grek C., Ye Z.W., Manevich Y., Tew K.D., Townsend D.M.: Pleiotropic functions of glutathione S-transferase P. Adv. Cancer Res., 2014; 122: 143-175
    Google Scholar
  • 57. Zhang J., Ye Z., Lou Y.: Metabolism of chlorambucil by rat liver microsomal glutathione S-transferase. Chem. Biol. Interact., 2004; 149: 61-67
    Google Scholar

Full text

Skip to content